Skip to content

Progressive Advancements in Neurosurgery, Data and Analysis Database

PANDA, Progressive Advancements in Neurosurgery, Data and Analysis Database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06835634
Acronym
PANDA
Enrollment
7500
Registered
2025-02-19
Start date
2025-01-15
Completion date
2035-12-31
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Nervous System Diseases, Peripheral Nervous System Diseases, Spine Disease

Brief summary

Neurosurgical diseases encompass a highly heterogeneous group of conditions, including oncological, malformative, traumatic, spinal, vascular, infectious diseases, and cerebrospinal fluid dynamics disorders. Several systematic reviews on the level of evidence in neurosurgical diseases have documented the low percentage of high-quality scientific evidence in this field of medicine. Clinical practice is strongly influenced by individual physician preferences, leading to significant heterogeneity among different centers both in Italy and internationally. This overall picture highlights the need for tools that can accurately characterize the numerous diagnostic variables influencing therapeutic outcomes in patients with neurosurgical diseases. Primary Objective To establish a prospective data collection of adult patients with neurosurgical diseases, providing real-life data on the current management of patients at the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome and the participating centers. Secondary Objectives To create a database of adult patients with neurosurgical diseases who may be potential candidates for enrollment in clinical trials. To conduct observational research on neurosurgical diseases, particularly in cases where no curative treatment options are currently available. To identify potential predictors of poor outcomes or treatment response. To assess the clinical history and treatment response of patients, including for internal audit purposes (e.g., supporting Morbidity & Mortality conferences). To provide support for the development and monitoring of quality indicators related to patient care.

Interventions

PROCEDURESelf reported questionnaires

PROMs and psychological tests submission in patients affected by neurosurgical diseases

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age at first contact equal to or greater than 18 years at the time of informed consent signature. * Diagnosis of a neurosurgical disease.

Exclusion criteria

* Refusal to provide written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Data collection of adult patients with neurosurgical diseases1 yearTo establish a prospective data collection of adult patients with neurosurgical diseases, providing real-life data on the current management of patients at the Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome and the participating centers.

Secondary

MeasureTime frameDescription
database of adult patients with neurosurgical diseases1 yearTo create a database of adult patients with neurosurgical diseases who may be potential candidates for enrollment in clinical trials.
observational research on neurosurgical diseases1 yearTo conduct observational research on neurosurgical diseases, particularly in cases where no curative treatment options are currently available.
potential predictors of treatment response1 yearTo identify potential predictors of poor outcomes or treatment response
development and monitoring of quality indicators1 yearTo provide support for the development and monitoring of quality indicators related to patient care.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026